NasdaqGS:ZVRAPharmaceuticals
Is Zevra Therapeutics (ZVRA) Using J.P. Morgan Spotlight To Reframe Its Rare-Disease Investment Story?
Zevra Therapeutics, Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026, at The Westin St. Francis Hotel’s 111 Minna Gallery in San Francisco.
This high-profile conference appearance gave Zevra a platform to highlight its rare disease focus and pipeline priorities to a concentrated audience of healthcare investors and industry partners.
We’ll now examine how Zevra’s high-visibility J.P. Morgan Healthcare Conference presentation may influence its...